FR2885807B1 - SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD - Google Patents

SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD

Info

Publication number
FR2885807B1
FR2885807B1 FR0504997A FR0504997A FR2885807B1 FR 2885807 B1 FR2885807 B1 FR 2885807B1 FR 0504997 A FR0504997 A FR 0504997A FR 0504997 A FR0504997 A FR 0504997A FR 2885807 B1 FR2885807 B1 FR 2885807B1
Authority
FR
France
Prior art keywords
trimethoxybenzyl
piperazine
preparation
pharmaceutical composition
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0504997A
Other languages
French (fr)
Other versions
FR2885807A1 (en
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MG PHARMA
Original Assignee
MG PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MG PHARMA filed Critical MG PHARMA
Priority to FR0504997A priority Critical patent/FR2885807B1/en
Priority to EA200702386A priority patent/EA013645B1/en
Priority to UAA200714180A priority patent/UA89408C2/en
Priority to PCT/FR2006/050128 priority patent/WO2006123073A1/en
Priority to EP06709507A priority patent/EP1881831A1/en
Publication of FR2885807A1 publication Critical patent/FR2885807A1/en
Application granted granted Critical
Publication of FR2885807B1 publication Critical patent/FR2885807B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0504997A 2005-05-18 2005-05-18 SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD Active FR2885807B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (en) 2005-05-18 2005-05-18 SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
EA200702386A EA013645B1 (en) 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
UAA200714180A UA89408C2 (en) 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
PCT/FR2006/050128 WO2006123073A1 (en) 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
EP06709507A EP1881831A1 (en) 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (en) 2005-05-18 2005-05-18 SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD

Publications (2)

Publication Number Publication Date
FR2885807A1 FR2885807A1 (en) 2006-11-24
FR2885807B1 true FR2885807B1 (en) 2008-05-16

Family

ID=35583424

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0504997A Active FR2885807B1 (en) 2005-05-18 2005-05-18 SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD

Country Status (5)

Country Link
EP (1) EP1881831A1 (en)
EA (1) EA013645B1 (en)
FR (1) FR2885807B1 (en)
UA (1) UA89408C2 (en)
WO (1) WO2006123073A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084397A2 (en) 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2187874A2 (en) * 2007-08-08 2010-05-26 Usv Limited Sustained release compositions of trimetazidine and process for preparation thereof
EP2200591A2 (en) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
TR201001902A2 (en) * 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
ES2508490T3 (en) * 2010-05-04 2014-10-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Formulation of trimetazidine with different release profiles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717687B1 (en) * 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.
FR2802424B1 (en) * 1999-12-17 2002-02-15 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
ATE442852T1 (en) * 2000-10-05 2009-10-15 Usv Ltd DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
FR2818549B1 (en) * 2000-12-26 2003-02-07 Servier Lab SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF TRIMETAZIDINE
HUP0500382A3 (en) * 2001-11-21 2008-03-28 Themis Lab Private Ltd Sustained release pharmaceutical compositions containing microbeads of trimetazidine dihydrochloride and process for producing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084397A2 (en) 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof

Also Published As

Publication number Publication date
WO2006123073A1 (en) 2006-11-23
EP1881831A1 (en) 2008-01-30
EA200702386A1 (en) 2008-04-28
FR2885807A1 (en) 2006-11-24
UA89408C2 (en) 2010-01-25
EA013645B1 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
DE602005015027D1 (en) GLUCOCORTICOID MIMETICS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
ATE397933T1 (en) CRYSTAL INFORMATION GAMMA-D OF IVABRADINE HYDROCHLORIDE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
HUP0500170A2 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
ZA200609687B (en) Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides
HK1121491A1 (en) Method for nucleic acid replication and novel artificial base pairs
ATE362771T1 (en) PHARMACEUTICAL IRESSA COMPOSITION CONTAINING A WATER-SOLUBLE CELLULOSE DERIVATIVE
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
ZA200801592B (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
ATE374172T1 (en) WEXIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THERAPEUTIC USES THEREOF
FR2885807B1 (en) SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
DE602006000102D1 (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
ATE503749T1 (en) BUTTERIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THERAPEUTIC USES THEREOF
DE602007005601D1 (en) PHARMACEUTICAL COMPOSITIONS, CONTAINING VALATOGRAST, AND METHOD FOR THE PRODUCTION THEREOF
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
ATE381338T1 (en) BENZOTHIADIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
GB0809228D0 (en) Compounds inducing differentiation of myoblasts or muscle f bers into neuron cells,pharmaceutical composition including said compounds.
HK1103958A1 (en) Pharmaceutical composition of piperazine derivatives
HK1093986A1 (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
DE602006011649D1 (en) NEW INDICATIVE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
DK1750765T3 (en) Pharmaceutical antimycobacterial composition comprising an antituberculous drug
ATE466863T1 (en) NEW AMINOPYRROLO-A1,2-AÜ-INDOLE AND AMINOPYRIDAZINO-A1,6-AÜ-INDOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREFROM
ATE405550T1 (en) POLYSUBSTITUTED 1,1-PYRIDINYLOXYCYCLOPROPANAMININE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HK1098146A1 (en) New polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
FR2867571B1 (en) METHOD FOR ANTI-COUNTERACTIVE MARKING OF A MANUFACTURED PRODUCT WITH A NON-RADIOACTIVE STABLE ISOTOPE
HUP0400953A3 (en) Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13